Fu et al., 2005 - Google Patents
Semiconductor nanocrystals for biological imagingFu et al., 2005
View PDF- Document ID
- 8100685622927958644
- Author
- Fu A
- Gu W
- Larabell C
- Alivisatos A
- Publication year
- Publication venue
- Current opinion in neurobiology
External Links
Snippet
Conventional organic fluorophores suffer from poor photo stability, narrow absorption spectra and broad emission spectra. Semiconductor nanocrystals, however, are highly photo-stable with broad absorption spectra and narrow size-tunable emission spectra …
- 238000003384 imaging method 0 title abstract description 42
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fu et al. | Semiconductor nanocrystals for biological imaging | |
| Alivisatos et al. | Quantum dots as cellular probes | |
| Rizvi et al. | Semiconductor quantum dots as fluorescent probes for in vitro and in vivo bio-molecular and cellular imaging | |
| Smith et al. | Multicolor quantum dots for molecular diagnostics of cancer | |
| Rhyner et al. | Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging | |
| Gao et al. | In vivo molecular and cellular imaging with quantum dots | |
| Xing et al. | Quantum dot bioconjugates for in vitro diagnostics & in vivo imaging | |
| Bajwa et al. | Pharmaceutical and biomedical applications of quantum dots | |
| Smith et al. | Chemical analysis and cellular imaging with quantum dots | |
| Mazumder et al. | Biofunctionalized quantum dots in biology and medicine | |
| Abbasi et al. | Biomedical and biological applications of quantum dots | |
| Ozkan | Quantum dots and other nanoparticles: what can they offer to drug discovery? | |
| Smith et al. | Engineering luminescent quantum dots for in vivo molecular and cellular imaging | |
| Biju et al. | Semiconductor quantum dots and metal nanoparticles: syntheses, optical properties, and biological applications | |
| Michalet et al. | Quantum dots for live cells, in vivo imaging, and diagnostics | |
| Smith et al. | Quantum dot nanocrystals for in vivo molecular and cellular imaging¶ | |
| Ji et al. | Fluorescent quantum dots: synthesis, biomedical optical imaging, and biosafety assessment | |
| Li et al. | Semiconductor quantum dots for in vivo imaging | |
| Bruchez | Turning all the lights on: quantum dots in cellular assays | |
| Cheki et al. | Marvelous applications of quantum dots. | |
| Dey et al. | Quantum dot: Novel carrier for drug delivery | |
| Lidke et al. | Imaging takes a quantum leap | |
| Li et al. | Bioconjugated quantum dots as fluorescent probes for biomedical imaging | |
| Gao et al. | Quantum dots for cancer molecular imaging | |
| Probst et al. | Luminescent nanoparticles and their use for in vitro and in vivo diagnostics |